(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual revenue growth rate of 346.96% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 108.19%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.27%.
Dbv Technologies Sa's revenue in 2025 is $5,503,000.On average, 3 Wall Street analysts forecast DBVT's revenue for 2025 to be $12,940,912,353, with the lowest DBVT revenue forecast at $584,625,781, and the highest DBVT revenue forecast at $26,280,256,393. On average, 3 Wall Street analysts forecast DBVT's revenue for 2026 to be $148,087,722,750, with the lowest DBVT revenue forecast at $143,689,077,520, and the highest DBVT revenue forecast at $153,952,583,057.
In 2027, DBVT is forecast to generate $23,055,259,678 in revenue, with the lowest revenue forecast at $22,370,349,521 and the highest revenue forecast at $23,968,473,221.